Evidence map›Paper›PMID 33619378›Full record

ArticleNature metabolism2021

The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity.

Crystal S Conn, Haojun Yang, Harrison J Tom, Kenji Ikeda, Juan A Oses-Prieto, Hieu Vu, Yasuo Oguri, Supna Nair, Ryan M Gill, Shingo Kajimura and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Using Imidazo[2,1-ACS medicinal chemistry letters · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Crystal S Conn *Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-3209-0445
Haojun Yang *Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Haojun.Yang@ucsf.edu.ORCID http://orcid.org/0000-0003-2685-3899
Harrison J TomHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-9402-2371
Kenji IkedaDiabetes Center, University of California, San Francisco, CA, USA.
Juan A Oses-PrietoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-4759-2341
Hieu VuChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Yasuo OguriDiabetes Center, University of California, San Francisco, CA, USA.
Supna NairDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-6499-0099
Ryan M GillDepartment of Pathology, University of California, San Francisco, CA, USA.
Shingo KajimuraDiabetes Center, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-0672-5910
Ralph J DeBerardinisChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-2705-7432
Alma L BurlingameHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-8403-7307
Davide RuggeroHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Davide.Ruggero@ucsf.edu.ORCID http://orcid.org/0000-0002-9444-5865
University of California, San Francisco · USHoward Hughes Medical Institute · USThe University of Texas Southwestern Medical Center · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Mechanisms of regulated translation control in cancer and its therapeutic implicationsR35CA242986 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUGGERO, DAVIDE · 2019 to 2025
$6.4M
Molecular mechanisms of UCP1-independent pathways in metabolic healthR01DK097441 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Shingo Kajimura · 2012 to 2026
$5.9M
Post-translational control of adipose tissue remodeling and metabolic healthR01DK127575 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAJIMURA, SHINGO · 2020 to 2025
$2.6M
elF4E-Dependent Translation Control in the Oncogenic Stress Response and CancerR01CA184624 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUGGERO, DAVIDE · 2014 to 2018
$1.9M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA184624NCI NIH HHS R35 CA242986NIDDK NIH HHS P30 DK020593NIDDK NIH HHS R01 DK097441NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Obesity is a global epidemic leading to increased mortality and susceptibility to comorbidities, with few viable therapeutic interventions. A hallmark of disease progression is the ectopic deposition of lipids in the form of lipid droplets in vital organs such as the liver. However, the mechanisms underlying the dynamic storage and processing of lipids in peripheral organs remain an outstanding question. Here, we show an unexpected function for the major cap-binding protein, eIF4E, in high-fat-diet-induced obesity. In response to lipid overload, select networks of proteins involved in fat deposition are altered in eIF4E-deficient mice. Specifically, distinct messenger RNAs involved in lipid metabolic processing and storage pathways are enhanced at the translation level by eIF4E. Failure to translationally upregulate these mRNAs results in increased fatty acid oxidation, which enhances energy expenditure. We further show that inhibition of eIF4E phosphorylation genetically-and by a potent clinical compound-restrains weight gain following intake of a high-fat diet. Together, our study uncovers translational control of lipid processing as a driver of high-fat-diet-induced weight gain and provides a pharmacological target to treat obesity.

Indexed as

Diet, High-FatAdipocytesAdipogenesisAnimalsEnergy MetabolismEukaryotic Initiation Factor-4EFatty AcidsLipid DropletsLipid MetabolismMaleMiceMice, Inbred C57BLMice, KnockoutObesityOxidation-ReductionPhosphorylationeIF4E protein, mouseEukaryotic Initiation Factor-4EFatty AcidsRNA, Messenger

Identifiers

PMID33619378
PMCPMC10350339
OpenAlexW3132196499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.